(Q71961918)
Statements
Evaluation of a somatostatin analog in the treatment of lymphoproliferative disorders: results of a phase II North Central Cancer Treatment Group trial (English)
T. E. Witzig
L. Letendre
J. Gerstner
G. Schroeder
J. A. Mailliard
G. Colon-Otero
R. F. Marschke